insights_auto
Why is PTX up 2.86%?
Dive Deeperchevron_right
PTX:ASX
Prescient Therapeutics Ltd
A$0.072
arrow_upward
+2.86%(+0.0020) 1D
Sep 29, 4:18:56 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Open
A$0.07
High
A$0.07
Low
A$0.07
Mkt. cap
75.71M
Avg. vol.
1.09M
Volume
1.24M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
Open
A$0.07
High
A$0.07
Low
A$0.07
Mkt. cap
75.71M
Avg. vol.
1.09M
Volume
1.24M
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
News stories
From web sources and news partners
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com